Bharat Biotech Commences Exports of Covid-19 Vaccine Covaxin

0
54


Covaxin has been created by Bharat Biotech in collaboration with ICMR-NIV and is one of the mainstays of India’s Covid-19 vaccination drive. (File Photo)

The company, however, did not provide details about the countries to which exports have commenced or about the additional countries to which the exports will start from December.

  • PTI New Delhi
  • Last Updated:November 29, 2021, 15:16 IST
  • FOLLOW US ON:

Vaccine maker Bharat Biotech on Monday said it has commenced exports of COVID-19 vaccine Covaxin, and long-pending export orders have been executed during November. “Long pending export orders have been executed during November, to be further expanded during the following months. With the number of countries that have granted emergency use approvals for Covaxin increasing, exports to additional countries will also commence from December,” Bharat Biotech said in a tweet.

The company, however, did not provide details about the countries to which exports have commenced or about the additional countries to which the exports will start from December. “Bharat Biotech thanks the Government of India for approving exports. Covaxin will now become an integral part of the global fight against this pandemic,” the tweet said.

Earlier last week, vaccine major Serum Institute of India had said that it has resumed exports of its vaccine Covishield to the international vaccine sharing programme COVAX.

Read all the Latest News, Breaking News and Coronavirus News here. Follow us on Facebook, Twitter and Telegram.





Source link